VER-01 significantly reduced pain intensity in chronic low back pain compared with placebo, with effects sustained during 12 months of treatment. VER-01 was generally well tolerated, with no signs of dependence, or withdrawal. In a […]
Resilience
New Report Breaks Down Risk Assessments for Practical Application as 80% of OCR Settlements Cite Documentation Failures
Regulatory Attorneys and Compliance Veterans Provide Clear Guidance on Healthcare’s Most Confusing Compliance Requirement as Enforcement Actions Intensify NEW YORK, Oct. 1, 2025 /PRNewswire/ — Compliancy Group released “Understanding and Applying Risk Assessment in Healthcare, […]
TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 – The World's First Apixaban Oral Dissolving Film – Represents a Transformational Advancement in Anticoagulant Therapy
TAIPEI, Oct. 1, 2025 /PRNewswire/ — TAHO Pharmaceuticals Ltd. (“TAHO Pharma”) today announced the submission of its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TAH3311, the world’s first Apixaban […]
Shrub Oak International School and The Pines at Shrub Oak Lead Ongoing Research to Advance Best Practices in Autism Education
Center for Autism Education Research, IRB, and partnerships drive continuous innovation for students MOHEGAN LAKE, N.Y., Sept. 30, 2025 /PRNewswire/ — Shrub Oak International School and The Pines at Shrub Oak continue to advance pioneering […]
HPV-Positive Oropharyngeal Cancer Market Poised for Strong Growth by 2034, Driven by Rising Incidence and Treatment Innovation | DelveInsight
The HPV+ oropharyngeal cancer market is expanding rapidly, driven by a rising incidence of HPV-driven OPSCC and growing clinician awareness. The anticipated launch of emerging therapies such as Merck Sharp & Dohme (KEYTRUDA), Bristol Myers […]
